Skip to content

CareDx CDNA Free cash flow yield

Free cash flow yield at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.7%+0.1pp
Natera, Inc. logo
Natera, Inc.NTRA
0.4%-0.1pp
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
-26%
Personalis, Inc. logo
Personalis, Inc.PSNL
-12.7%-1.7pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-23.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
4.7%-0.5pp

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.47B+40.4%
Enterprise value$1.42B+40.6%
P/S3.6×+0.5×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

Based on trailing twelve months.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's free cash flow yield?
CareDx (CDNA) reported free cash flow yield of -0% in Q1 2025.
How has CareDx's free cash flow yield changed year-over-year?
CareDx's free cash flow yield increased by 98.3% year-over-year, from -0.9% to -0%.
What is the long-term trend for CareDx's free cash flow yield?
Over 3 years (2020 to 2024), CareDx's free cash flow yield has grown at a 55.5% compound annual growth rate (CAGR), from 0.9% to 3.3%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.